Interactions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells

Journal of Endocrinology

Volumn 208, Issue 1, 2011, Pages 1-9

  Mendoza, Rhone A ^a   Enriquez, Marlene I ^a   Mejia, Sylvia M ^a   Moody, Emily E ^a   Thordarson, Gudmundur ^a  

^a Paul L Foster School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROGESTERONE RECEPTOR; PROTEIN P53; SMALL INTERFERING RNA; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; EXPRESSION VECTOR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANALYSIS OF VARIANCE; APOPTOSIS; BLOTTING, WESTERN; CELL COUNT; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; INSULIN-LIKE GROWTH FACTOR I; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78650968836     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-10-0235     Document Type: Article

References (46)

1. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, Trentalance A, Muramatsu M & Marino M 2005 Survival versus apoptotic 17β-estradiol effect: role of ERα and ERβ activated non-genomic signaling. Journal of Cellular Physiology 203 195-201. (doi:10.1002/jcp.20219) (Pubitemid 40330938)
2. Bradley LM, Gierthy JF & Pentecost BT 2008 Role of insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line. Journal of Steroid Biochemistry and Molecular Biology 109 186-196. (doi:10.1016/j.jsbmb.2007.10.006)
3. Bulavin DV & Fornace AJ Jr 2004 p38 MAP kinase's emerging role as a tumor suppressor. Advances in Cancer Research 92 95-118. (doi:10.1016/S0065- 230X(04)92005-2)
4. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E & Fornace A Jr 1999 Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO Journal 18 6845-6854. (doi:10.1093/emboj/18.23.6845)
5. Chang EC, Frasor J, Komm B & Katzenellenbogen BS 2006 Impact of estrogen receptor β on gene networks regulated by estrogen receptor α in breast cancer cells. Endocrinology 147 4831-4842. (doi:10.1210/en.2006-0563)
6. Fagan DH & Yee D 2008 Crosstalk between IGF1R and estrogen receptor signaling in breast cancer. Journal of Mammary Gland Biology and Neoplasia 13 423-429. (doi:10.1007/s10911-008-9098-0)
7. Forster C, Makela S, Warri A, Kietz S, Becker D, Hultenby K, Warner M & Gustafsson J-A 2002 Involvement of estrogen receptor β in terminal differentiation of mammary gland epithelium. PNAS 99 15578-15583. (doi:10.1073/pnas.192561299)
8. Galluzzo P, Caiazza F, Moreno S & Marino M 2007 Role of ERβ palmitoylation in the inhibition of human colon cancer cell proliferation. Endocrine-Related Cancer 14 153-167. (doi:10.1677/ERC-06-0020)
9. Hagg M, Biven K, Ueno T, Rydlander L, Bjorklund P, Wiman KG, Shoshan M & Linder S 2002 A novel high-through-put assay for screening of pro-apoptotic drugs. Investigational New Drugs 20 253-259. (doi:10.1023/A: 1016249728664)
10. Hall JM & McDonnell DP 1999 The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140 5566-5578. (doi:10.1210/en.140.12.5566)
11. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Strom A, Treuter E, Warner M et al. 2007 Estrogen receptors: how do they signal and what are their targets. Physiological Reviews 87 905-931. (doi:10.1152/physrev.00026.2006) (Pubitemid 47084672)
12. Hershberger PA, Stabile LP, Kanterewicz B, Rothstein ME, Gubish CT, Land S, Shuai Y, Siegfried JM & Nichols M 2009 Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. Journal of Steroid Biochemistry and Molecular Biology 116 102-109. (doi:10.1016/j.jsbmb.2009.05.004)
13. Hinegardner RT 1971 An improved fluorometric assay for DNA. Analytical Biochemistry 39 197-201. (doi:10.1016/0003-2697(71)90476-3)
14. Hodges-Gallagher L, Valentine CD, El Bader S & Kushner PJ 2008 Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Breast Cancer Research and Treatment 109 241-250. (doi:10.1007/s10549-007-9640-6)
15. Hopp TA,Weiss HL, Parra IS, Cui Y, Osborne CK & Fuqua SAW2004 Low levels of estrogen receptor β protein predict resistance to tamoxifen therapy in breast cancer. Clinical Cancer Research 10 7490-7499. (doi:10.1158/1078-0432.CCR-04-1114)
16. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S,Gotoh Y, Nishida E, KawashimaHet al. 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 1491-1494. (doi:10.1126/science.270.5241.1491)
17. Kleinberg DL & Ruan W 2008 IGF-I, GH, and sex steroid effects in normal mammary gland development. Journal of Mammary Gland Biology and Neoplasia 13 353-360. (doi:10.1007/s10911-008-9103-7)
18. Kleinberg DL, Feldman M & Ruan W 2000 IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis. Journal of Mammary Gland Biology and Neoplasia 5 7-17. (doi:10.1023/A:1009507030633)
19. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Research 29 2905-2919. (doi:10.1093/nar/29.14.2905)
20. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson J-A & Smithies O 1998 Generation and reproductive phenotypes of mice lacking estrogen receptor β. PNAS 95 15677-15682. (doi:10.1073/pnas.95.26.15677)
21. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK & Yee D 1999 Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Molecular Endocrinology 13 787-796. (doi:10.1210/me.13.5.787)
22. Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson J-A & Ohlsson C 2003 Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a "Ying Yang" relationship between ERα and ERβ in mice. Molecular Endocrinology 17 203-208. (doi:10.1210/me.2002-0206)
23. Liu M-M, Albanese C, Anderson CM, Hilty K,Webb P, Uht RM, Price RH Jr, Pestell RG & Kushner PJ 2002 Opposing action of estrogen receptors α and β on cyclin D1 gene expression. Journal of Biological Chemistry 277 24353-24360. (doi:10.1074/jbc.M201829200)
24. Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H & Papa MZ 2006 Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. Journal of Endocrinology 191 605-612. (doi:10.1677/joe.1.07016)
25. Matthews J & Gustafsson J-A 2003 Estrogen signaling: a subtle balance between ERα and ERβ. Molecular Interventions 3 281-292. (doi:10.1124/mi.3.5.281)
26. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ & Scanlan TS 1997 Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277 1508-1510. (doi:10.1126/science.277.5331. 1508)
27. Pedram A, Razandi M & Levin ER 2006 Nature of functional estrogen receptors at the plasma membrane. Molecular Endocrinology 20 1996-2009. (doi:10.1210/me.2005-0525) (Pubitemid 44286700)
28. Pettersson K, Delaunay F & Gustafsson J-A 2000 Estrogen receptor β acts as a dominant regulator of estrogen signaling. Oncogene 19 4970-4978. (doi:10.1038/sj.onc.1203828)
29. Razandi M, Pedram A, Greene GL & Levin ER 1999 Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Molecular Endocrinology 13 307-319. (doi:10.1210/me.13.2.307)
30. Razandi M, Pedram A, Merchenthaler I, Greene GL & Levin ER 2004 Plasma membrane estrogen receptors exist and functions as dimers. Molecular Endocrinology 18 2854-2865. (doi:10.1210/me.2004-0115)
31. Roger P, Sahla ME, Makela S, Gustafsson J-A, Baldet P & Rochefort H 2001 Decreased expression of estrogen receptor β protein in proliferative preinvasive mammary tumors. Cancer Research 61 2537-2541.
32. Santen R, Song RX, McPherson R, Kumar R, Adam L, Jeng M-H & Yue W 2002 The role of mitogen-activated protein (MAP) kinase in breast cancer. Journal of Steroid Biochemistry and Molecular Biology 80 239-256. (doi:10.1016/S0960-0760(01)00189-3)
33. Saville B, Poukka H,Wormke M, Janne OA, Palvimo JJ, Stoner M, Samudio I & Safe S 2002 Cooperative coactivation of estrogen receptor α in ZR-75 human breast cancer cells by SNURF and TATA-binding protein. Journal of Biological Chemistry 277 2485-2497. (doi:10.1074/jbc.M109021200)
34. Schutte B, Henfling M, Kolgen W, Bouman M, Meex S, Leers MPG, Nap M, Bjorklund V, Bjorklund P, Bjorklund B et al. 2004 Keratin 8/18 breakdown and reorganization during apoptosis. Experimental Cell Research 297 11-26. (doi:10.1016/j.yexcr.2004.02.019)
35. Sisci D & Surmacz E 2007 Crosstalk between IGF signaling and steroid hormone receptors in breast cancer. Current Pharmaceutical Design 13 705-717. (doi:10.2174/138161207780249182)
36. Song XR, Barnes CJ, Zhang Z, Bao Y, Kumar R & Santen R 2004 The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor α to the plasma membrane. PNAS 101 2076-2081. (doi:10.1073/pnas.0308334100)
37. Song RX-D, Zhang Z, Chen Y, Bao Y & Santen RJ 2007 Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology 148 4091-4101. (doi:10.1210/en.2007-0240)
38. Song RX-D, Chen Y, Zhang Z, Bao Y, Yue W, Wang J-P, Fan P & Santen RJ 2010 Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 118 219-230. (doi:10.1016/j.jsbmb.2009.09.018)
39. Stewart AJ, Johnson MD, May JEB & Westley BR 1990 Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. Journal of Biological Chemistry 265 21172-21178.
40. Thordarson G, Lee AV, McCarty M, Van Horn K, Chu O, Chou Y-C, Yang J, Guzman RC, Nandi S & Talamantes F 2001 Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Carcinogenesis 22 2039-2047. (doi:10.1093/carcin/22.12.2039)
41. Thordarson G, Semaan S, Low C, Ochoa D, Leong H, Rajkumar L, Guzman RC, Nandi S & Talamantes F 2004a Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects on hormonal treatments. Breast Cancer Research and Treatment 87 277-290. (doi:10.1007/s10549-004-9504-2) (Pubitemid 39505945)
42. Thordarson G, Slusher N, Leong H, Ochoa D, Rajkumar L, Guzman R, Nandi S & Talamantes F 2004b Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcino-genesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway. Breast Cancer Research 6 R423-R436. (doi:10.1186/bcr812)
43. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Bon TL, Kathuria S, Chen E et al. 1986 Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO Journal 5 2503-2512.
44. Xia Z, Dickens M, Raingeaud J, Davis RJ & Greenberg ME 1995 Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 1326-1331. (doi:10.1126/science.270.5240.1326)
45. Zhao C, Matthews J, Tujague M, Wan J, Strom A, Toresson G, Lam EW-F, Cheng G, Gustafsson J-A & Dahlman-Wright K 2007 Estrogen receptor β2 negatively regulates the transactivation of estrogen receptor α in human breast cancer cells. Cancer Research 67 3955-3962. (doi:10.1158/0008-5472.CAN- 06-3505)
46. Zhao C, Dahlman-Wright K & Gustafsson J-A 2008 Estrogen receptor β: an overview and update.NuclearReceptor Signaling6 e003. (doi:10.1621/nrs.06003)